
Deferoxamine
Form: Lyophilized powder for injection
Strength: 500 mg/vial, 2 g/vial
Reference Brands: Desferal
Category: Anemia
Deferoxamine (Desferal®) is a trusted parenteral iron chelator used in the treatment of acute iron poisoning and chronic iron overload due to frequent blood transfusions, especially in thalassemia and sickle cell disease. Available as 500 mg and 2 g lyophilized powder for injection, it is administered via IV, IM, or subcutaneous infusion. Marketed under the brand Desferal in the US and EU, it’s manufactured under GMP-compliant standards for hospital and clinical use. Ideal for global B2B pharmaceutical procurement. Contact us for bulk export, COAs, and regulatory support documents.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Deferasirox
Strength: 125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View Details Get EnquiryIron(III)-Isomaltoside Injection
Strength: 100mg/ml
Form: Injection
Reference Brands: Monofer,, Diafer, Monoferric
View Details Get EnquiryIron Dextran
Strength: 50 mg/mL
Form: injection
Reference Brands: Dexferrum,INFeD
View Details Get EnquiryPolysaccharide-Iron Complex
Strength: 150 mg
Form: Capsules
Reference Brands: Niferex, Ferrex 150, Ferrousal
View Details Get Enquiry